E-resources
Peer reviewed
Open access
-
Du, Wenjuan; Hurdiss, Daniel L; Drabek, Dubravka; Mykytyn, Anna Z; Kaiser, Franziska K; González-Hernández, Mariana; Muñoz-Santos, Diego; Lamers, Mart M; van Haperen, Rien; Li, Wentao; Drulyte, Ieva; Wang, Chunyan; Sola, Isabel; Armando, Federico; Beythien, Georg; Ciurkiewicz, Malgorzata; Baumgärtner, Wolfgang; Guilfoyle, Kate; Smits, Tony; van der Lee, Joline; van Kuppeveld, Frank J M; van Amerongen, Geert; Haagmans, Bart L; Enjuanes, Luis; Osterhaus, Albert D M E; Grosveld, Frank; Bosch, Berend-Jan
Science immunology, 07/2022, Volume: 7, Issue: 73Journal Article
The ongoing evolution of SARS-CoV-2 has resulted in the emergence of Omicron, which displays notable immune escape potential through mutations at key antigenic sites on the spike protein. Many of these mutations localize to the spike protein ACE2 receptor binding domain, annulling the neutralizing activity of therapeutic antibodies that were effective against other variants of concern (VOCs) earlier in the pandemic. Here, we identified a receptor-blocking human monoclonal antibody, 87G7, that retained potent in vitro neutralizing activity against SARS-CoV-2 variants including the Alpha, Beta, Gamma, Delta, and Omicron (BA.1/BA.2) VOCs. Using cryo-electron microscopy and site-directed mutagenesis experiments, we showed that 87G7 targets a patch of hydrophobic residues in the ACE2-binding site that are highly conserved in SARS-CoV-2 variants, explaining its broad neutralization capacity. 87G7 protected mice and hamsters prophylactically against challenge with all current SARS-CoV-2 VOCs and showed therapeutic activity against SARS-CoV-2 challenge in both animal models. Our findings demonstrate that 87G7 holds promise as a prophylactic or therapeutic agent for COVID-19 that is more resilient to SARS-CoV-2 antigenic diversity.
Author
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.